Related Experiment Videos

[Hyperhomocysteinemia-related cerebral venous thrombosis]

M C Fernández-Moreno1, L Castilla-Guerra, A Castella-Murillo

  • 1Servicio de Neurología, Hospital Universitario Virgen de Valme, Sevilla, España. castillafernandez@hotmail.com

Revista De Neurologia
|December 12, 2003
PubMed

Insights

Moderate hyperhomocysteinemia is a risk factor for blood clots. This case report highlights a young woman with cerebral venous sinus thrombosis linked to high homocysteine levels, emphasizing the need for awareness and potential supplementation.

Area of Science:

  • Neurology
  • Hematology
  • Cardiovascular Medicine

Background:

  • Moderate hyperhomocysteinemia is a known risk factor for atherosclerosis and venous thromboembolism.
  • Cerebral venous thrombosis (CVT) is a rare but serious condition.
  • Few cases link hyperhomocysteinemia to CVT in medical literature.

Observation:

  • A 21-year-old woman using oral contraceptives presented with headache, nausea, and vomiting.
  • Clinical examination revealed papilledema.
  • Imaging confirmed thrombosis of the left lateral sinus.

Findings:

  • Hypercoagulability studies revealed persistently high homocysteine levels.
  • Immunologic tests for autoimmune conditions were negative.
  • The patient improved with anticoagulant therapy and management of brain edema.

Implications:

  • Hypercoagulable states, including moderate hyperhomocysteinemia, are present in 70% of CVT patients.
  • Homocysteine may induce endothelial dysfunction, contributing to venous thrombosis.
  • Oral contraceptives can elevate venous thrombosis risk in prothrombotic states; folic acid and vitamin supplementation are discussed.
Abstract

Related Concept Videos